The latest thoracic oncology news
Immune checkpoint inhibitors significantly increase myocarditis risk in NSCLC patients
A new editorial was published in Volume 12 of Oncoscience on May 2, 2025, titled “Immune checkpoint inhibitors…
Browsing: Lung Cancer
Symposium preparing Victorian healthcare workers for National Lung Cancer Screening Program
The National Lung Cancer Screening Program rolls out on 1 July. The Victorian Comprehensive Cancer…
Non-risk-based lung cancer screening with low-dose computed tomography
In 2015, the First Affiliated Hospital of Guangzhou Medical University, in collaboration with the Guangdong…
European Commission approves subcutaneous amivantamab for the treatment of patients with advanced EGFR-mutated non-small cell lung cancer
It has been announced that the European Commission (EC) has approved an extension of marketing…
Predicting the response of the most common lung cancer drugs
Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In…
Advancements in managing EGFR-mutant and ALK-positive non–small cell lung cancer with brain metastases
Recent findings published in JAMA Oncology shed light on the optimal management strategies for patients…
Non small cell lung cancer with SMARCA4 deficiency harbouring rare EGFR mutations exhibited significant tumour response when treated with afatinib
Lung cancers with SMARCA4 deficiency are rare, typically showing aggressive behaviour and poor prognosis. These…
Preventive healthcare utilisation among adults eligible for lung cancer screening
A recent study published in JAMA on 3 April 2025, titled “Preventive Health Care Use…
Breakthrough combination therapy tackles drug resistance in lung cancer with common KRAS mutation
A breakthrough in lung cancer treatment may be on the horizon. Scientists at VCU Massey…
New approach identifies reproducible VOCs for lung cancer diagnosis
A research team led by Prof. CHU Yannan from the Hefei Institutes of Physical Science…